Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lasagna

Showing results (21-30 of 199) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|November 1, 1976
Drug discovery and introduction: regulation and overregulationL Lasagna
Lijecnicki Vjesnik|February 1, 1980
[Clinical pharmacology in USA and Western Countries (author's transl)]L Lasagna
Journal of the American Geriatrics Society|September 1, 1983
Generic drugs and the elderlyL Lasagna
Drug Therapeutics|January 1, 1982
Patient package inserts: goals versus achievementsL Lasagna
British Journal of Clinical Pharmacology|January 1, 1981
Bias in the elucidation of subjective side-effectsL Lasagna
Perspectives in Biology and Medicine|January 1, 1989
Congress, the FDA, and new drug development: before and after 1962L Lasagna
The New England Journal of Medicine|October 10, 1974
Letter: Abuse of amphetaminesL Lasagna
Pharmacoeconomics|December 8, 1997
Defining our future workL Lasagna
Hospital Formulary|December 14, 1975
The problems of drug research and developmentL Lasagna
The American Review of Respiratory Disease|September 1, 1980
Regulation and constraint of medical research: rights and human welfareL Lasagna
Pageof 20

Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|November 1, 1976
Drug discovery and introduction: regulation and overregulationL Lasagna
Lijecnicki Vjesnik|February 1, 1980
[Clinical pharmacology in USA and Western Countries (author's transl)]L Lasagna
Journal of the American Geriatrics Society|September 1, 1983
Generic drugs and the elderlyL Lasagna
Drug Therapeutics|January 1, 1982
Patient package inserts: goals versus achievementsL Lasagna
British Journal of Clinical Pharmacology|January 1, 1981
Bias in the elucidation of subjective side-effectsL Lasagna
Perspectives in Biology and Medicine|January 1, 1989
Congress, the FDA, and new drug development: before and after 1962L Lasagna
The New England Journal of Medicine|October 10, 1974
Letter: Abuse of amphetaminesL Lasagna
Pharmacoeconomics|December 8, 1997
Defining our future workL Lasagna
Hospital Formulary|December 14, 1975
The problems of drug research and developmentL Lasagna
The American Review of Respiratory Disease|September 1, 1980
Regulation and constraint of medical research: rights and human welfareL Lasagna
Pageof 20